Lixisenatide Reduces Motor Disability Progression in Parkinson Disease

THURSDAY, April 4, 2024-- For patients with Parkinson disease, lixisenatide yields less progression of motor disability than placebo, according to a study published in the April 4 issue of the New England Journal of Medicine.Wassilios G. Meissner,...